SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001610618-18-000015
Filing Date
2018-03-19
Accepted
2018-03-19 08:06:36
Documents
3
Period of Report
2018-03-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a8-k2018x03x19.htm 8-K 49434
2 STRIVE TOPLINE DATA RELEASE ex9912018-03x19.htm EX-99.1 41670
3 cdtxlogosec.jpg GRAPHIC 63449
  Complete submission text file 0001610618-18-000015.txt   179748
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 18697521
SIC: 2836 Biological Products, (No Diagnostic Substances)